TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07217990: Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer

Sponsor: Ohio State University Comprehensive Cancer Center · Phase: PHASE1/PHASE2 · Area: ONCOLOGY · Target Enrollment: 84 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$12,566,400

Rescue Site Savings

+$8,285,970

Unlock Full NCT07217990 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07217990 Rescue Dossier →